As a company that was started by a scientist, Dr Reddy’s fosters a culture where scientific temperament is rooted in our people and our approach to research. Our research efforts accelerate access to affordable and innovative medicines. We focus our work on being first to market with products that are difficult to make. Why? These tough-to-make products are likely to be very expensive and our capabilities allow us to improve accessibility to them.
At the heart of our organisation are our state-of-the-art R&D Centres. These centres house over 75 laboratories with more than 1000 research scientists working on various projects. Work at the R&D Centres provides a wide-ranging suite of capabilities and services - from synthetic organic chemistry to formulations development; from intellectual property management to regulatory science; from polymorphism to biopharmaceuticals. The success of our research organization can be judged by the fact that we have over 170 ANDAs, over 500 DMFs and 86 patents filed in the last five years.
To know more about Dr. Reddy’s please visit us at www.drreddys.com
About the Cambridge R&D Centre
At our Cambridge R&D Centre, we are committed to meeting the ever-increasing demand to develop high-quality pharmaceuticals using the most cost-effective, environmentally sustainable and innovative processes possible. This is core to our company’s belief that “Good Health Can’t Wait” and complements our research philosophy that access to medicines should not be a privilege – it is a right.
At the heart of every medicine is the active ingredient. Accelerating access to innovative and affordable medicines begins with making active ingredients more affordable. In Cambridge, we focus on developing technical solutions for the production of highly complex APIs. With a history in world-leading asymmetric catalysis together with continuous processing and high quality analytical support, our teams develop cleaner, quicker, and more efficient routes to these complex molecules.